Nano-X Imaging (NNOX) CEO Erez Meltzer adds 9,443 shares via owned company
Rhea-AI Filing Summary
Nano-X Imaging Ltd. director and Chief Executive Officer Erez Meltzer reported purchasing 9,443 Ordinary Shares on August 10, 2026 at $1.03 per share. The shares were bought indirectly through Oud Nof, a company wholly owned by him, bringing that entity’s holdings to 45,443 Ordinary Shares. He also reports direct ownership of 60,584 Ordinary Shares, and three existing stock option grants over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively. The later option grant from April 16, 2024 vests over four years and is scheduled to be fully vested by April 16, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 9,443 shares
Net Buy
5 txns
Insider
Meltzer Erez
Role
Chief Executive Officer
Bought
9,443 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares F1 | 9,443 | $1.03 | $10K |
| holding | Stock Option (right to buy ordinary shares) F2, F3 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2, F4 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2, F5 | -- | -- | -- |
| holding | Ordinary Shares F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 45,443 shares (Indirect, By a wholly owned company);
Stock Option (right to buy ordinary shares) — 490,234 shares (Direct);
Ordinary Shares — 60,584 shares (Direct)
Footnotes (5)
- F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
- F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
- F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Key Figures
Shares purchased: 9,443 Ordinary Shares
Purchase price: $1.03 per share
Indirect holdings after transaction: 45,443 Ordinary Shares
+3 more
6 metrics
Shares purchased
9,443 Ordinary Shares
Indirect purchase on August 10, 2026
Purchase price
$1.03 per share
Price for 9,443 Ordinary Shares purchased
Indirect holdings after transaction
45,443 Ordinary Shares
Held through wholly owned company Oud Nof
Direct Ordinary Share holdings
60,584 Ordinary Shares
Reported direct ownership position
Option exercise price
$2.21
Stock option over 40,234 underlying shares expiring 2030-02-11
Largest option grant size
300,000 underlying shares
Stock option at $23.84 exercise price expiring 2032-01-02
Key Terms
indirect ownership, fully vested and exercisable, vesting schedule, Rule 10b5-1
4 terms
indirect ownership financial
"Indirect ownership is noted as "By a wholly owned company" for the purchase."
fully vested and exercisable financial
"The options reported in this row were granted ... and are fully vested and exercisable."
vesting schedule financial
"The options ... vest and become exercisable in accordance with the following schedule."
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is not checked for this transaction."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Nano-X Imaging (NNOX) report for Erez Meltzer?
Erez Meltzer reported purchasing 9,443 Ordinary Shares of Nano-X Imaging on August 10, 2026 at $1.03 per share, an indirect open-market or private transaction through a wholly owned company.
What stock options for Nano-X Imaging (NNOX) does Erez Meltzer hold?
Meltzer holds options over 40,234, 300,000, and 150,000 underlying Ordinary Shares at exercise prices of $2.21, $23.84, and $11.52, expiring in 2030, 2032, and 2034, respectively, as reported for informational purposes.
Are Erez Meltzer’s NNOX stock options vested and exercisable?
Options granted in January and February 2020 are reported as fully vested and exercisable. Options granted on April 16, 2024 vest over four years and are scheduled to be fully vested by April 16, 2028.